Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.

The Journal of antibiotics - 1 Nov 2014

Imperiale Belén Rocío, Di Giulio Ángela Beatríz, Adrián Cataldi Angel, Morcillo Nora Susana

Abstract excerpt

The emergence of drug-resistant, multidrug-resistant and extensively drug-resistant tuberculosis (TB) is of major public health concern in several countries. In this study, the pharmacodynamic relationships among the structural analogs of antibiotics belonging to the same family were taken into c...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antitubercular Agents
Share to Colorimetry
Share to Fluoroquinolones

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Isoniazid

Share to Levofloxacin

Share to Moxifloxacin

Share to Rifampin

Share to Tuberculosis

Source

Identifiers

PMID: 24894185
DOI: 10.1038/ja.2014.61

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24894185-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.PMID 24894185Read ↗

Co-resistance to isoniazid and second-line anti-tuberculosis drugs in isoniazid-resistant tuberculosis at a tertiary care hospital in Thailand.Semantic proximity Read ↗

Mechanisms of drug resistance in Mycobacterium tuberculosis.Semantic proximity Read ↗

Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.Semantic proximity Read ↗

Mycobacterium Tuberculosis: Drug Resistance and Future PerspectivesSemantic proximity Read ↗

Molecular characterization of multidrug-resistant tuberculosis against levofloxacin, moxifloxacin, bedaquiline, linezolid, clofazimine, and delamanid in southwest of China.Semantic proximity Read ↗

In vitro antimicrobial resistance properties of rifapentine and rifampicin are indistinguishable.Semantic proximity Read ↗

Drug susceptibility of the Mycobacterium genus: in vitro tests and clinical implications.Semantic proximity Read ↗

Molecular determinants of drug resistance in tuberculosis.Semantic proximity Read ↗

Fluoroquinolone resistance in Mycobacterium tuberculosis and mutations in gyrA and gyrB.Semantic proximity Read ↗

Molecular Characterization of Levofloxacin, Moxifloxacin, Bedaquiline, Linezolid, Clofazimine, and Delamanid against Multidrug-resistant Tuberculosis in Southwest of ChinaSemantic proximity Read ↗

Correlation of different phenotypic drug susceptibility testing methods for four fluoroquinolones inMycobacterium tuberculosisSemantic proximity Read ↗

Acquisition of cross-resistance to Bedaquiline and Clofazimine following treatment for Tuberculosis in PakistanSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.